Home/ Supplements/ Zinc/ MaxoMan

MaxoMan

product on market Tablet or Pill Supplement Spot Safety: 85/100
85/100

This product is generally safe

  • Zinc: 50mg is 1.2× the Tolerable Upper Intake Level (40mg)
  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 43% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains ingredients like Tongkat Ali, Maca, and Panax ginseng, which have moderate evidence for supporting libido and energy. L-Arginine and Zinc are commonly used to support reproductive health and hormonal balance. Overall, research coverage for this specific combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Zinc: 50mg is 1.2× the Tolerable Upper Intake Level (40mg)

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for MaxoMan
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
43%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

50 mg (455% DV)
Exceeds UL by 1.2× (UL: 40 mg) 263 studies (A:6, B:134)
Tongkat Ali, Powder
500 mg
250 mg
Market median: 500.0mg (357 products) 1 studies — no high-quality reviews
Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)
Market median: 450.0mg (390 products) 160 studies (A:0, B:63)
Eleutherococcus senticosus Root Extract
67.5 mg
Proprietary Blend
838 mg

Other Ingredients

Microcrystalline Cellulose Stearic Acid Calcium Carbonate Magnesium Stearate Croscarmellose Sodium Hydroxypropyl Methylcellulose Silicon Dioxide
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: 2 tablets daily preferably with meals or as directed by a healthcare professional.

Warnings & Precautions

Caution: Do not exceed recommended dose.

This product is not intended for pregnant or nursing mothers, children under the age of 18, or individuals taking prescription drugs.

This product is not intended for pregnant or nursing mothers, children under the age of 18, or individuals taking prescription drugs.

Discontinue use immediately if nausea, sleeplessness, or nervousness occur.

If you have a known medical condition including high blood pressure, diabetes, any cardiovascular disorder, heart disease, hyperthyroidism, if you are taking antidepressant medications or have questions about the advisability of taking this product, consult your physician before using this or any dietary supplement.

This product is manufactured and packaged in a facility which may also process milk, soy, wheat, egg, peanuts, tree nuts, fish and crustacean shellfish.

Keep out of the reach of children.

Do not use if safety seal is damaged or missing.

Allergen warning: Contains shellfish (oyster).

Formulation Notes

Natural male libido formula

Natural male libido formula

Non-GMO formula

Additional Information

Store in a cool, dry place.

Formulated in USA Sourced from a GMP Certified Facility

Formulated in USA

Metadata

Product Details

DSLD Entry Date2025-06-25
Product TypeOther Combinations
FormTablet or Pill
DSLD ID328359
Data Updated2026-04-11
Research

Research Evidence

397
Research Sources
55
Avg Quality
200
Meta Analysis
68
Rct
58
Systematic Review
53
Clinical Trial
9
Cochrane Review
2
Narrative Review
2
Regulatory Source
1
Observational
1
Other
1
Openfda Safety
A Zinc supplementation for improving pregnancy and infant outcome
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years
Narrative Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Oral zinc for treating diarrhoea in children
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2021 PubMed DOI
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2010 PubMed DOI
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Compression bandages or stockings versus no compression for treating venous leg ulcers
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Zinc supplementation for mental and motor development in children
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Zinc for the common cold
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Zinc →
Compare

Similar Products

View all Zinc products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.